Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
6 February 2015
Header
Header image
News

News

EUCROF Congress Focus on Clinical Trial Regulation
06 February 2015

This week the 2nd Annual Conference of EUCROF took place in Paris.  Discussions focused on the new Clinical Trials Regulation (536/2014) and delegates were united [...] Read more

News

Disclosure of payments to health professionals: Going Live
06 February 2015

Delegates from across industry and the health professional community came together in Rotterdam last week to discuss the challenges and opportunities of the public disclosure [...] Read more

From our blog

From our blog

21st Century Cures Moves Towards Development of MAPPs Infrastructures and Methodologies
06 February 2015 by Magda Chlebus

While Europe is leading in the development of tools and methodologies in Medicine's Adaptive Pathways (MAPPs) through the EMA live pilots and upcoming projects in IMI2, the key bottlenecks still holding back its implementation in Europe are gaining traction with the United States congress. This situation illustrates our need in Europe to move quickly and develop implementation strategies and foster political support for MAPPs whilst we still hold the drive and initiative.

Read more

What we are reading

What we are reading

Towards the taxonomy of human disease
06 February 2015 (Nature Reviews)

In 2012, the European Innovative Medicines Initiative (IMI) published a call for proposals to establish 'mechanism-based taxonomies' for inflammatory diseases (focusing on systemic lupus erythematosus and rheumatoid arthritis), and for neurodegenerative diseases (focusing on Alzheimer disease and Parkinson disease).

Two proposals have been selected as IMI programmes after review: PRECISESADS for inflammatory diseases and AETIONOMY for neurodegenerative diseases.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail